Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Study of E7130 in Subjects With Solid Tumor

Trial Profile

A Phase 1 Study of E7130 in Subjects With Solid Tumor

Phase of Trial: Phase I

Latest Information Update: 07 Feb 2019

At a glance

  • Drugs E-7130 (Primary)
  • Indications Adenocarcinoma; Breast cancer; Colon cancer; Gastric cancer; Head and neck cancer; Oesophageal cancer; Rectal cancer; Solid tumours; Squamous cell cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 27 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top